Meeting Banner
Abstract #2547

MRI enhancement of TPP-TEMPOL during reduces kidney damage

Quan Tao1, Peiwei Yi1, Zimeng Cai1, Yingjie Mei2, Ruiyuan Liu1, and Yanqiu Feng1
1School of Biomedical Engineering, Southern Medical University, Guangzhou, China, 2Philips healthcare, Guangzhou, China

In this study, we synthesis a mitochondria-targeted contrast agent named triphenylphosphine-2,2,6,6-tetramethylpiperidine-1-oxyl (TPP-TEMPOL) to protect the kidney from the damage induced by rhabdomyolysis. At the same time, measured the T1 changes by MRI.

This abstract and the presentation materials are available to members only; a login is required.

Join Here